Development of Metal-Based Drugs and Application in Clinical Treatment

被引:1
|
作者
Shao, Yi Ming [1 ,4 ]
Sharavyn, Bold [2 ]
Huang, Ping [3 ]
Naranmandura, Hua [1 ,4 ,5 ]
Wang, Qian Qian [4 ,5 ]
机构
[1] Inner Mongolia Med Univ, Coll Pharmaceut Sci, Hohhot, Peoples R China
[2] Mongolian Natl Univ Med Sci, Dept Pharmacol, Ulan Bator, Mongolia
[3] Zhejiang Prov Peoples Hosp, Dept Pharm, Hangzhou, Peoples R China
[4] Zhejiang Univ, Dept Pharmacol, Sch Med, Hangzhou 310058, Peoples R China
[5] Zhejiang Univ, Sch Med & Publ Hlth, Dept Hematol & Oncol, Hangzhou 310058, Peoples R China
来源
NATURAL PRODUCTS JOURNAL | 2022年 / 12卷 / 03期
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Metals; cancer; selenium; platinum; arsenic; antimony; APL; SELENIUM; THERAPY; CANCER; LEISHMANIASIS; METABOLISM; PREVENTION; RESISTANCE; ANTIMONY;
D O I
10.2174/2210315511666210512025010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metals occur naturally in soil and many kinds of rocks, particularly in minerals and ores, which also play a vital role in living systems such as plants and animals. Over the large time scale, metal evolution from toxins to drugs has achieved a milestone mean in medicine. Currently, a few metal-based drugs (i.e., metallodrugs) have been used in the clinic to treat patients with different medical conditions, making exciting new developments in anticancer therapeutics (e.g., arsenic trioxide and cisplatin) that quickly move into focus. Moreover, a thorough understanding of the properties and effects of metals on the human body could improve the development and innovation of metal-based drugs. In this review, we have comprehensively described the discovery and development of metal-based anticancer drugs, as well as their side effects in clinical treatment. Although metallodrugs have shown promising outcomes in the treatment of cancers, further investigation is needed to optimize their side effect for broader applications.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 50 条
  • [1] Frontier of the Research and Development of Metal-based Drugs Foreword
    Odani, Akira
    Sakurai, Hiromu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2012, 132 (03): : 251 - 251
  • [2] Metal-based Drugs Foreword
    Dyson, Paul J.
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2010, 63 (11) : 1503 - 1504
  • [3] METAL-BASED DRUGS IN CHEMOTHERAPY
    Theophanides, T.
    Anastassopoulou, J.
    Theodorakopoulou, O.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3652 - 3653
  • [4] Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs
    Todorov, Lozan
    Kostova, Irena
    MOLECULES, 2023, 28 (04):
  • [5] Capillary electrophoresis of metal-based drugs
    Timerbaev, Andrei R.
    Keppler, Bernhard K.
    ANALYTICAL BIOCHEMISTRY, 2007, 369 (01) : 1 - 7
  • [6] Metal-based drugs that break the rules
    Allardyce, Claire S.
    Dyson, Paul J.
    DALTON TRANSACTIONS, 2016, 45 (08) : 3201 - 3209
  • [7] Metal-based drugs for diagnosis and therapy
    Alves, Susana
    Vitor, Rute
    Raposinho, Paula D.
    Marques, Fernanda
    Correia, Joao D. G.
    Paulo, Antonio
    Santos, Isabel
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 9, 2006, 9 : 3 - +
  • [8] Development of trackable metal-based drugs: new generation of therapeutic agents
    Bertrand, Benoit
    Doulain, Pierre-Emmanuel
    Goze, Christine
    Bodio, Ewen
    DALTON TRANSACTIONS, 2016, 45 (33) : 13005 - 13011
  • [9] Selenosemicarbazone Metal Complexes as Potential Metal-based Drugs
    Rostan, Santiago
    Mahler, Graciela
    Otero, Lucia
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (05) : 558 - 572
  • [10] Application of ICP-MS to the development of metal-based drugs and diagnostic agents: where do we stand?
    Timerbaev, Andrei R.
    JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY, 2021, 36 (02) : 254 - 266